Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
Active, not recruiting · NCT05783596 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-09-25 | NCT05783596 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genentech, Inc. | 221 |
| Reid Merryman, MD | 3 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| Columbia University Irving Medical Center | New York | United States | 234 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Mount Sinai Medical Center | New York | United States | 1 |